On the other way, SIRT1 and c-Myc can work synergistically to stimulate hepatocellular proliferation in HCC cells and adjust each other through a positive feedback way, which results in poor treatment outcome [79] (Figure 2). This evidence concerns the gene SIRT1 and hepatocellular carcinoma.